Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA316313
Max Phase: Preclinical
Molecular Formula: C22H20BrF3N2O2
Molecular Weight: 481.31
Molecule Type: Small molecule
Associated Items:
ID: ALA316313
Max Phase: Preclinical
Molecular Formula: C22H20BrF3N2O2
Molecular Weight: 481.31
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(N/C(C(=O)N1CCCCC1)=C(/Br)c1ccccc1)c1ccc(C(F)(F)F)cc1
Standard InChI: InChI=1S/C22H20BrF3N2O2/c23-18(15-7-3-1-4-8-15)19(21(30)28-13-5-2-6-14-28)27-20(29)16-9-11-17(12-10-16)22(24,25)26/h1,3-4,7-12H,2,5-6,13-14H2,(H,27,29)/b19-18+
Standard InChI Key: FTYHAOQMLYJMBV-VHEBQXMUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 481.31 | Molecular Weight (Monoisotopic): 480.0660 | AlogP: 5.21 | #Rotatable Bonds: 4 |
Polar Surface Area: 49.41 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.89 | CX Basic pKa: | CX LogP: 4.34 | CX LogD: 4.34 |
Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.61 | Np Likeness Score: -1.06 |
1. Perni RB, Conway SC, Ladner SK, Zaifert K, Otto MJ, King RW.. (2000) Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication., 10 (23): [PMID:11128652] [10.1016/s0960-894x(00)00544-8] |
Source(1):